Send the following on WhatsApp
Continue to ChatFDA adcomm narrowly votes in favor of Merck's antiviral for outpatient Covid-19 https://invesbrain.com/fda-adcomm-narrowly-votes-in-favor-of-mercks-antiviral-for-outpatient-covid-19/
FDA adcomm narrowly votes in favor of Merck's antiviral for outpatient Covid-19 https://invesbrain.com/fda-adcomm-narrowly-votes-in-favor-of-mercks-antiviral-for-outpatient-covid-19/